New price gets Clovis’ PARP inhibitor on the CDF
Experts discuss the implications of the new, reinvigorated Cancer Drugs Fund, for pharma and patients.
The world’s first national database of cancer treatment outcomes has been launched in England.
Assessing HCPs’ social media comments about the new approach to cancer drug funding.
Liver cancer treatment latest earmarked for removal from CDF